ROFERON (RIFN-ALPHA(2A)) IS MORE IMMUNOGENIC THAN INTRON-A (RIFN-ALPHA(2B)) IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA

被引：30
|
作者：
VONWUSSOW, P
HEHLMANN, R
HOCHHAUS, T
JAKSCHIES, D
NOLTE, KU
PRUMMER, O
ANSARI, H
HASFORD, J
HEIMPEL, H
DEICHER, H
机构：
[1] UNIV HEIDELBERG, HOSP MED 3, DEPT HAEMATOL, D-69115 HEIDELBERG, GERMANY
[2] BIOMETR CTR THERAPEUT STUDIES, W-8000 MUNICH, GERMANY
[3] UNIV ULM, DEPT HAEMATOL ONCOL, W-7900 ULM, GERMANY
来源：
JOURNAL OF INTERFERON RESEARCH | 1994年 / 14卷 / 04期
关键词：
D O I：
10.1089/jir.1994.14.217
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：217 / 219
页数：3
相关论文
共 50 条
  • [41] Phase I study of polyethylene glycol (PEG) interferon alpha-2B (intron-A) in CML patients
    Talpaz, M
    Cortes, J
    O'Brien, S
    Keating, M
    Giles, F
    Rose, E
    Rybak, ME
    Kantarjian, H
    [J]. BLOOD, 1998, 92 (10) : 251A - 251A
  • [42] Acral sclerosis due to interferon-alpha-2b in chronic myelogenous leukemia
    Saydam, G
    Bozkurt, D
    Sahin, F
    Yuksel, S
    Hekimgil, M
    Omay, SB
    Buyukkececi, F
    [J]. ACTA HAEMATOLOGICA, 2002, 107 (01) : 43 - 45
  • [43] Pegylated interferon alpha 2b induces less thyroid dysfunction than standard interferon alpha 2b in the treatment of chronic hepatitis C
    Patel, Y
    Chapalamadugu, R
    Ramdhaney, S
    Baradarian, R
    Iswara, K
    Tenner, S
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S87 - S88
  • [44] Prevalence of thyroid dysfunction in patients with chronic hepatitis C infection receiving pegylated interferon alpha 2a versus alpha 2b, plus ribavirin
    Gan, E. K.
    Miczkova, S.
    Andrews, G.
    Booth, L.
    Mollison, L. C.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A271 - A271
  • [45] Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemia
    Millot, Frederic
    Guilhot, Joelle
    Nelken, Brigitte
    Leblanc, Thierry
    Leverger, Guy
    Bernard, Frederic
    Gandemer, Virginie
    Behard, Catherine
    Berger, Claire
    Cornu, Guy
    Duchene, Sylvain
    Guilhot, Francois
    [J]. PEDIATRIC BLOOD & CANCER, 2006, 47 (05) : 555 - 559
  • [46] Low-dose interferon-alpha 2b combined with hydroxyurea versus hydroxyurea alone for chronic myelogenous leukemia
    Louwagie, A
    Delannoy, A
    KluinNelemans, JC
    [J]. BONE MARROW TRANSPLANTATION, 1996, 17 : S19 - S20
  • [47] A RANDOMIZED DOUBLE-BLIND TRIAL OF INTERFERON ALFA-2A (RIFN-ALPHA-2A) IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS-C
    FURUTA, S
    OHASHI, Y
    [J]. HEPATOLOGY, 1992, 16 (02) : 536 - 536
  • [48] SUPPRESSION OF ERYTHROPOIESIS IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA BY RECOMBINANT ALPHA-2 INTERFERON
    MCGLAVE, PB
    MAMUS, SW
    [J]. CLINICAL RESEARCH, 1985, 33 (04): : A836 - A836
  • [49] Treatment Profile of Hepatitis C Patients - A Comparison of Interferon Alpha 2a and 2b Treatment Regimes
    Aziz, Sina
    Qamar, Rana
    Ahmed, Iftikhar
    Imran, Khalid
    Masroor, Muhammad
    Rajper, Jamila
    Nafay, Saba
    Noorulain, Wajeeha
    Khan, Masood Hameed
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2010, 20 (09): : 581 - 585
  • [50] HEPATIC HISTOLOGY PREDICTS THE OUTCOME OF INTERFERON (RIFN ALPHA-2B) THERAPY IN CHRONIC ACTIVE HEPATITIS-C (CAH-C)
    GARCIABUEY, L
    GARCIAMONZON, C
    GARCIASANCHEZ, A
    MORENOOTERO, R
    [J]. HEPATOLOGY, 1991, 14 (04) : A204 - A204
12345